US EditionHow shoddy science is fueling a charge to restrict abortion pill access
- Robert F. Kennedy Jr., head of the Department of Health and Human Services, has directed the FDA to conduct a safety evaluation of mifepristone after a new report was released in April.
- This review was prompted by a non-peer-reviewed report claiming mifepristone causes serious complications at a rate 22 times higher than FDA data indicates.
- Researchers and public health experts criticized the report for flawed methods, ideological bias, and broad definitions of complications including normal side effects.
- Kennedy indicated that any adjustments to policy would be decided at the highest level, with President Trump having the final authority over regulatory decisions.
- The review could lead to policy changes restricting mifepristone access amid ongoing political efforts by anti-abortion groups and some lawmakers.
4 Articles
4 Articles
Abortion providers challenge FDA’s remaining mifepristone restrictions in federal court • Nebraska Examiner
“We just want to ensure that the most popular method for abortion in Virginia and beyond is protected no matter who sits at the White House and who sits in the FDA,” said Whole Woman’s Health founder and president Amy Hagstrom Miller outside of the U.S. District Court of the Western District of Virginia in Charlottesville, Virginia, on May 19, 2025. (Photo by Charlotte Rene Woods/Virginia Mercury)CHARLOTTESVILLE, Va. — Abortion pills — and quest…
How shoddy science is fueling a charge to restrict abortion pill access – Mnnofa
Health and Human Services Secretary Robert F. Kennedy Jr. has tasked the Food and Drug Administration with conducting a safety review of mifepristone, a pill used in most U.S. abortions. Kennedy said this week that the review was warranted due to an “alarming” new report on serious adverse events released last month. “Clearly it indicates that, at very least, the label should be changed,” he told Sen. Josh Hawley, R-Mo., at a Senate budget heari…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
